These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21953630)

  • 1. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
    Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
    Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
    Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
    J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
    Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
    Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.
    Jensen HK; Donskov F; Marcussen N; Nordsmark M; Lundbeck F; von der Maase H
    J Clin Oncol; 2009 Oct; 27(28):4709-17. PubMed ID: 19720929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer.
    Sienel W; Dango S; Woelfle U; Morresi-Hauf A; Wagener C; Brümmer J; Mutschler W; Passlick B; Pantel K
    Clin Cancer Res; 2003 Jun; 9(6):2260-6. PubMed ID: 12796394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.
    Kobayashi N; Usui S; Kikuchi S; Goto Y; Sakai M; Onizuka M; Sato Y
    Lung Cancer; 2012 Feb; 75(2):223-7. PubMed ID: 21764477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer.
    Donnem T; Al-Shibli K; Andersen S; Al-Saad S; Busund LT; Bremnes RM
    Cancer; 2010 Sep; 116(18):4318-25. PubMed ID: 20549821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
    Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
    Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
    Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
    Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
    Teramukai S; Kitano T; Kishida Y; Kawahara M; Kubota K; Komuta K; Minato K; Mio T; Fujita Y; Yonei T; Nakano K; Tsuboi M; Shibata K; Furuse K; Fukushima M
    Eur J Cancer; 2009 Jul; 45(11):1950-8. PubMed ID: 19231158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
    Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
    Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
    Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.